Safety and Efficacy of TRO19622 as add-on Therapy to Riluzole Versus Placebo in Treatment of Patients Suffering From Amyotrophic Lateral Sclerosis (ALS) (MITOTARGET)
This study has been completed.
First Posted: March 24, 2009
Last Update Posted: March 28, 2012
Information provided by (Responsible Party):